The Vaccines Key Account Manager (KAM) is a commercial sales role with clear accountability for revenue growth, account penetration, and portfolio adoption within assigned key accounts in Finland. The role owns the commercial outcome in each account and is responsible for identifying, prioritising, and converting opportunities into measurable sales results, with a primary focus on pneumococcal vaccines. The KAM leads commercial engagement across both public and private segments outside the National Immunisation Programs (NIPs), translating market and system knowledge into concrete actions that remove barriers to purchase, accelerate uptake, and grow account value. While cross‑functional support is mobilised as needed, the KAM retains full commercial ownership of account strategy, execution, and results. The role is field‑based, with up to 80% customer‑facing time, and requires disciplined prioritisation to ensure field activity directly advances account growth and return on inves...